You have read all your free articles, to continue reading subscribe to read the rest of this content.
By combining Redoxis’ expertise in immunology with Cellevates’ 3D cell culture systems based on nanomaterials the companies have created a 3D in-vitro model of a cytokine storm to help pharma companies test the effectiveness of anti-corona drugs. "Working closely with Redoxis to further expanAlready a subscriber Login You have read…
Scandion Oncology has announced that Johnny Stilou has been appointed as the company’s new CFO, and joins the company, effective no later than August 1, 2021. He has a long experience from both Danish and international listed companies – most recently Nuevolution AB and Amgen Inc, states the Already a…
The company has announced the relocation into new corporate headquarters located at Sydmarken 11 in Søborg, and the appointment of a new Chief Financial Officer. The move will accommodate Zealand’s continued workforce growth, which has been steadily increasing to support the number of clinicalAlready a subscriber Login You have read…
Since 2014, Ville Paavilainen’s laboratory at the University of Helsinki has been investigating a molecule, which now shows promise in targeting the new coronavirus. This work could lead to development of a new drug to help alleviate symptoms and prevent progression of COVID-19, states the reseAlready a subscriber Login You…
